Purine nucleoside phosphorylase deficiency.
Markert ML.
Immunodefic Rev. 1991;3(1):45-81.
Combined immunodeficiency due to purine nucleoside phosphorylase deficiency: Outcome of three patients.
Torun B, Bilgin A, Orhan D, Gocmen R, Kılıc SS, Kuskonmaz B, Cetinkaya D, Tezcan I, Cagdas D.
Eur J Med Genet. 2022 Mar;65(3):104428. doi: 10.1016/j.ejmg.2022.104428. Epub 2022 Jan 19.
[Purine nucleoside phosphorylase (PNP) deficiency].
Sakiyama T.
Nihon Rinsho. 1996 Dec;54(12):3328-32.
Purine nucleoside phosphorylase deficiency induces p53-mediated intrinsic apoptosis in human induced pluripotent stem cell-derived neurons.
Tsui M, Biro J, Chan J, Min W, Dobbs K, Notarangelo LD, Grunebaum E.
Sci Rep. 2022 May 31;12(1):9084. doi: 10.1038/s41598-022-10935-0.
[Purine nucleoside phosphorylase].
Pogosian LG, Akopian ZhI.
Biomed Khim. 2013 Sep-Oct;59(5):483-97. doi: 10.18097/pbmc20135905483.
The First Purine Nucleoside Phosphorylase Deficiency Patient Resembling IgA Deficiency and a Review of the Literature.
Fekrvand S, Yazdani R, Abolhassani H, Ghaffari J, Aghamohammadi A.
Immunol Invest. 2019 May;48(4):410-430. doi: 10.1080/08820139.2019.1570249. Epub 2019 Mar 19.
Purine Nucleoside Phosphorylase Deficiency in Two Unrelated Patients with Autoimmune Hemolytic Anemia and Eosinophilia: Two Novel Mutations.
Alizadeh Z, Badalzadeh M, Heydarlou H, Shakerian L, Mahlooji Rad M, Zandieh F, Fazlollahi MR.
Arch Iran Med. 2023 Dec 1;26(12):712-716. doi: 10.34172/aim.2023.105.
[Purine nucleoside phosphorylase deficiency].
Sakiyama Y.
Ryoikibetsu Shokogun Shirizu. 2000;(32):43-5.
Purine Nucleoside Phosphorylase Deficiency: A Case Report of an Extremely Rare Disorder.
Alasmari BG, Ibrahim F, Wafa S, Alshehri A, Saeed M.
Cureus. 2024 Dec 22;16(12):e76220. doi: 10.7759/cureus.76220. eCollection 2024 Dec.
MTAP as an emerging biomarker in thoracic malignancies.
Brune MM, Savic Prince S, Vlajnic T, Chijioke O, Roma L, König D, Bubendorf L.
Lung Cancer. 2024 Nov;197:107963. doi: 10.1016/j.lungcan.2024.107963. Epub 2024 Sep 29.
